Pentavalent Bio Sciences Private Limited, a active private limited company, was established on 24 February 2015 in Bangalore South, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85110KA2015PTC078991. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.81 M.
It upholds a compliant status. Its leadership includes Murali Shripathy Harishchandra (Director), Soumya Paul (Director). Past directors included Raghavendra Maddur Puttaswamy, Murali Shripathy Harishchandra, Bhavani Venkataswamachari Peddayelachagiri. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-202, 1St Floor, Kssidc Block-1,, Electronic City Phase-1, Hosur Road,, Bangalore South, Karnataka, 560100.
U85110KA2015PTC078991
078991
24 February 2015
₹2.00 M
₹1.81 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Pentavalent Bio Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Murali Shripathy Harishchandra | Director | 04 Dec 2015 | Current |
| Soumya Paul | Director | 24 Feb 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 25 Jul 2016 | Past |
| Pramod Abcsdd | Director | 01 Aug 2020 | Past |
| Pramod Abcsdd | Director | 24 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pentavalent Bio Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 356.01% increase. The company also saw a substantial improvement in profitability, with a 300.13% increase in profit. The company's net worth Soared by an impressive increase of 145.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pentavalent Bio Sciences had a public holding of 5.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2023 | Sidbi | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Pentavalent Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pentavalent Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pentavalent Bio Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pentavalent Bio Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Pentavalent Bio Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100872078 was registered on 01 Dec 2023. was completed.
Murali Shripathy Harishchandra was appointed as a Director was appointed as a Director on 04 Dec 2015 & has been associated with this company since 9 years 11 months . was recorded as a recent event.
Progress on Soumya Paul was appointed as a Director was appointed as a Director on 24 Feb 2015 & has been associated with this company since 10 years 9 months . was documented.
The activity Pentavalent Bio Sciences Private Limited was registered on 24 Feb 2015 with Roc Bangalore & aged 10 years 9 months as per MCA records. was completed.
The CIN of Pentavalent Bio Sciences Private Limited is U85110KA2015PTC078991.
Pentavalent Bio Sciences Private Limited is headquartered at B-202, 1St Floor, Kssidc Block-1,, Electronic City Phase-1, Hosur Road,, Bangalore South, Karnataka, 560100.
Pentavalent Bio Sciences Private Limited was incorporated on 24 February 2015.
The current directors of Pentavalent Bio Sciences Private Limited are
The primary industry of Pentavalent Bio Sciences Private Limited is Manufacturing.
Pentavalent Bio Sciences Private Limited is unlisted.
The authorized capital of Pentavalent Bio Sciences Private Limited is ₹2.00 M, and the paid-up capital is ₹1.81 M.
The compliance status of Pentavalent Bio Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX